• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Kinetic mechanism of dihydropyrimidine dehydrogenase from pig liver.

作者信息

Podschun B, Cook P F, Schnackerz K D

机构信息

Institute of Physiological Chemistry, University of Würzburg, Federal Republic of Germany.

出版信息

J Biol Chem. 1990 Aug 5;265(22):12966-72.

PMID:2198281
Abstract

Data on initial velocity and isotope exchange at equilibrium suggest a nonclassical ping-pong mechanism for the dihydropyrimidine dehydrogenase from pig liver. Initial velocity patterns in the absence of inhibitors appeared parallel at low reactant concentration, with substrate inhibition by NADPH that is competitive with uracil and with substrate inhibition by uracil that is uncompetitive with NADPH. The Km values for both uracil (1 microM) and NADPH (7 microM) are low. As a result, it was difficult to determine whether the initial velocity pattern in the absence of added inhibitors was parallel. Thus, the pattern was redetermined in the presence of the dead-end inhibitor 2,6-dihydroxypyridine, which binds to both sites. This treatment effectively eliminates the inhibition by both substrates and increases their Km values, giving a strictly parallel pattern. Product and dead-end inhibition patterns are consistent with a mechanism in which NADPH reduces the enzyme at site 1 and electrons are transferred to site 2 to reduce uracil to dihydrouracil. The predicted mechanism is corroborated by exchange between [14C] NADP and NADPH as well as [14C]thymine and dihydrothymine in the absence of the other substrate-product pair.

摘要

相似文献

1
Kinetic mechanism of dihydropyrimidine dehydrogenase from pig liver.
J Biol Chem. 1990 Aug 5;265(22):12966-72.
2
Dihydropyrimidine dehydrogenase. Kinetic mechanism for reduction of uracil by NADPH.
J Biol Chem. 1993 Sep 15;268(26):19321-7.
3
Stereochemistry of NADPH oxidation by dihydropyrimidine dehydrogenase from pig liver.猪肝二氢嘧啶脱氢酶催化NADPH氧化的立体化学
Biochem Biophys Res Commun. 1992 Jan 31;182(2):609-16. doi: 10.1016/0006-291x(92)91776-m.
4
Porcine recombinant dihydropyrimidine dehydrogenase: comparison of the spectroscopic and catalytic properties of the wild-type and C671A mutant enzymes.猪重组二氢嘧啶脱氢酶:野生型和C671A突变体酶的光谱和催化特性比较。
Biochemistry. 1998 Dec 15;37(50):17598-609. doi: 10.1021/bi9815997.
5
Purification and characterization of dihydropyrimidine dehydrogenase from Alcaligenes eutrophus.
Arch Biochem Biophys. 1996 Aug 1;332(1):175-82. doi: 10.1006/abbi.1996.0330.
6
Acid base catalytic mechanism of the dihydropyrimidine dehydrogenase from pH studies.通过pH研究对二氢嘧啶脱氢酶的酸碱催化机制进行研究。
J Biol Chem. 1993 Feb 15;268(5):3407-13.
7
Purification and properties of dihydrothymine dehydrogenase from rat liver.大鼠肝脏二氢胸腺嘧啶脱氢酶的纯化及性质
J Biol Chem. 1981 Jan 10;256(1):219-24.
8
Kinetic mechanism for the model reaction of NADPH-cytochrome P450 oxidoreductase with cytochrome c.NADPH-细胞色素P450氧化还原酶与细胞色素c模型反应的动力学机制。
Biochemistry. 1994 Oct 11;33(40):12012-21. doi: 10.1021/bi00206a002.
9
Effects of uridine and thymidine on the degradation of 5-fluorouracil, uracil, and thymine by rat liver dihydropyrimidine dehydrogenase.尿苷和胸苷对大鼠肝脏二氢嘧啶脱氢酶降解5-氟尿嘧啶、尿嘧啶和胸腺嘧啶的影响。
Cancer Res. 1985 Nov;45(11 Pt 1):5553-6.
10
Combined deficiencies of NADPH- and NADH-dependent dihydropyrimidine dehydrogenases, a new finding in a family with thymine-uraciluria.NADPH和NADH依赖的二氢嘧啶脱氢酶联合缺乏症:一个患有胸腺嘧啶-尿嘧啶尿症的家族中的新发现
J Inherit Metab Dis. 1995;18(2):185-8. doi: 10.1007/BF00711762.

引用本文的文献

1
Identification of fungal dihydrouracil-oxidase genes by expression in Saccharomyces cerevisiae.通过在酿酒酵母中表达鉴定真菌二氢尿嘧啶氧化酶基因。
Antonie Van Leeuwenhoek. 2022 Nov;115(11):1363-1378. doi: 10.1007/s10482-022-01779-9. Epub 2022 Oct 14.
2
Force Field Parameters for FeS Clusters of Dihydropyrimidine Dehydrogenase, the 5-Fluorouracil Cancer Drug Deactivation Protein: A Step towards In Silico Pharmacogenomics Studies.二氢嘧啶脱氢酶(5-氟尿嘧啶癌症药物失活蛋白)的FeS簇的力场参数:迈向计算机药物基因组学研究的一步。
Molecules. 2021 May 14;26(10):2929. doi: 10.3390/molecules26102929.
3
A ferredoxin-dependent dihydropyrimidine dehydrogenase in Clostridium chromiireducens.
梭菌属中依赖于ferredoxin 的二氢嘧啶脱氢酶。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20201642.
4
Hypermutation of DPYD Deregulates Pyrimidine Metabolism and Promotes Malignant Progression.DPYD的高突变使嘧啶代谢失调并促进恶性进展。
Mol Cancer Res. 2016 Feb;14(2):196-206. doi: 10.1158/1541-7786.MCR-15-0403. Epub 2015 Nov 25.
5
Crystal structure of dihydropyrimidine dehydrogenase, a major determinant of the pharmacokinetics of the anti-cancer drug 5-fluorouracil.二氢嘧啶脱氢酶的晶体结构,抗癌药物5-氟尿嘧啶药代动力学的主要决定因素。
EMBO J. 2001 Feb 15;20(4):650-60. doi: 10.1093/emboj/20.4.650.